Protein Solubility and Aggregation in Bacteria

Proteins suffer many conformational changes and interactions through their life, from their synthesis at ribosomes to their controlled degradation. Only folded and soluble proteins are functional. Thus, protein folding and solubility are controlled genetically, transcriptionally, and at the protein...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2016
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (127 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546772204498
ctrlnum (CKB)3800000000216195
(oapen)https://directory.doabooks.org/handle/20.500.12854/57245
(EXLCZ)993800000000216195
collection bib_alma
record_format marc
spelling Salvador Ventura auth
Protein Solubility and Aggregation in Bacteria
Frontiers Media SA 2016
1 electronic resource (127 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Frontiers Research Topics
Proteins suffer many conformational changes and interactions through their life, from their synthesis at ribosomes to their controlled degradation. Only folded and soluble proteins are functional. Thus, protein folding and solubility are controlled genetically, transcriptionally, and at the protein sequence level. In addition, a well-conserved cellular machinery assists the folding of polypeptides to avoid misfolding and ensure the attainment of soluble and functional structures. When these redundant protective strategies are overcome, misfolded proteins are recruited into aggregates. Recombinant protein production is an essential tool for the biotechnology industry and also supports expanding areas of basic and biomedical research, including structural genomics and proteomics. Although bacteria still represent a convenient production system, many recombinant polypeptides produced in prokaryotic hosts undergo irregular or incomplete folding processes that usually result in their accumulation as insoluble aggregates, narrowing thus the spectrum of protein-based drugs that are available in the biotechnology market. In fact, the solubility of bacterially produced proteins is of major concern in production processes, and many orthogonal strategies have been exploited to try to increase soluble protein yields. Importantly, contrary to the usual assumption that the bacterial aggregates formed during protein production are totally inactive, the presence of a fraction of molecules in a native-like structure in these assemblies endorse them with a certain degree of biological activity, a property that is allowing the use of bacteria as factories to produce new functional materials and catalysts. The protein embedded in intracellular bacterial deposits might display different conformations, but they are usually enriched in beta-sheet-rich assemblies resembling the amyloid fibrils characteristic of several human neurodegenerative diseases. This makes bacterial cells simple, but biologically relevant model systems to address the mechanisms behind amyloid formation and the cellular impact of protein aggregates. Interestingly, bacteria also exploit the structural principles behind amyloid formation for functional purposes such as adhesion or cytotoxicity. In the present research topic we collect papers addressing all the issues mentioned above from both the experimental and computational point of view.
English
protein aggregation
bacterial chaperones
Bacteria
Functional amyloids
protein expression
Protein Folding
Prion-like proteins
2-88919-976-2
language English
format eBook
author Salvador Ventura
spellingShingle Salvador Ventura
Protein Solubility and Aggregation in Bacteria
Frontiers Research Topics
author_facet Salvador Ventura
author_variant s v sv
author_sort Salvador Ventura
title Protein Solubility and Aggregation in Bacteria
title_full Protein Solubility and Aggregation in Bacteria
title_fullStr Protein Solubility and Aggregation in Bacteria
title_full_unstemmed Protein Solubility and Aggregation in Bacteria
title_auth Protein Solubility and Aggregation in Bacteria
title_new Protein Solubility and Aggregation in Bacteria
title_sort protein solubility and aggregation in bacteria
series Frontiers Research Topics
series2 Frontiers Research Topics
publisher Frontiers Media SA
publishDate 2016
physical 1 electronic resource (127 p.)
isbn 2-88919-976-2
illustrated Not Illustrated
work_keys_str_mv AT salvadorventura proteinsolubilityandaggregationinbacteria
status_str n
ids_txt_mv (CKB)3800000000216195
(oapen)https://directory.doabooks.org/handle/20.500.12854/57245
(EXLCZ)993800000000216195
carrierType_str_mv cr
hierarchy_parent_title Frontiers Research Topics
is_hierarchy_title Protein Solubility and Aggregation in Bacteria
container_title Frontiers Research Topics
_version_ 1787548858607206401
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03451nam-a2200349z--4500</leader><controlfield tag="001">993546772204498</controlfield><controlfield tag="005">20231214133547.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2016 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3800000000216195</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/57245</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993800000000216195</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Salvador Ventura</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Protein Solubility and Aggregation in Bacteria</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (127 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Proteins suffer many conformational changes and interactions through their life, from their synthesis at ribosomes to their controlled degradation. Only folded and soluble proteins are functional. Thus, protein folding and solubility are controlled genetically, transcriptionally, and at the protein sequence level. In addition, a well-conserved cellular machinery assists the folding of polypeptides to avoid misfolding and ensure the attainment of soluble and functional structures. When these redundant protective strategies are overcome, misfolded proteins are recruited into aggregates. Recombinant protein production is an essential tool for the biotechnology industry and also supports expanding areas of basic and biomedical research, including structural genomics and proteomics. Although bacteria still represent a convenient production system, many recombinant polypeptides produced in prokaryotic hosts undergo irregular or incomplete folding processes that usually result in their accumulation as insoluble aggregates, narrowing thus the spectrum of protein-based drugs that are available in the biotechnology market. In fact, the solubility of bacterially produced proteins is of major concern in production processes, and many orthogonal strategies have been exploited to try to increase soluble protein yields. Importantly, contrary to the usual assumption that the bacterial aggregates formed during protein production are totally inactive, the presence of a fraction of molecules in a native-like structure in these assemblies endorse them with a certain degree of biological activity, a property that is allowing the use of bacteria as factories to produce new functional materials and catalysts. The protein embedded in intracellular bacterial deposits might display different conformations, but they are usually enriched in beta-sheet-rich assemblies resembling the amyloid fibrils characteristic of several human neurodegenerative diseases. This makes bacterial cells simple, but biologically relevant model systems to address the mechanisms behind amyloid formation and the cellular impact of protein aggregates. Interestingly, bacteria also exploit the structural principles behind amyloid formation for functional purposes such as adhesion or cytotoxicity. In the present research topic we collect papers addressing all the issues mentioned above from both the experimental and computational point of view.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein aggregation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacterial chaperones</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Functional amyloids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein expression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Protein Folding</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Prion-like proteins</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88919-976-2</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:57:44 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2017-09-30 19:47:25 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338344180004498&amp;Force_direct=true</subfield><subfield code="Z">5338344180004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338344180004498</subfield></datafield></record></collection>